title: A desensitization protocol for the mAb cetuximab.
authors.forename: Maya R
authors.initials: MR
authors.lastname: Jerath
authors.forename: Mildred
authors.initials: M
authors.lastname: Kwan
authors.forename: Mily
authors.initials: M
authors.lastname: Kannarkat
authors.forename: Beloo
authors.initials: B
authors.lastname: Mirakhur
authors.forename: Lisa
authors.initials: L
authors.lastname: Carey
authors.forename: John
authors.initials: J
authors.lastname: Valgus
authors.forename: Thomas A E
authors.initials: TA
authors.lastname: Platts-Mills
authors.forename: Teresa K
authors.initials: TK
authors.lastname: Tarrant
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects; D000068818:Cetuximab; D003888:Desensitization, Immunologic / Q000379:methods*; D004342:Drug Hypersensitivity / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D016190:Carboplatin; D000068818:Cetuximab